| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.12 | 8e-05 |
| mRNA | 968 | CTRPv2 | pan-cancer | AAC | 0.25 | 0.0001 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0004 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0004 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.15 | 0.0006 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.0008 |
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.093 | 0.003 |